Withdrawal Research Studies

Royal College of Psychiatrists’ former president demands support for patients coming off antidepressants.

Antidepressant users share their frustrations towards a healthcare system that overprescribes but is ill-equipped to support with discontinuation and withdrawal symptoms.

Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.

Adverse physiological symptoms of antidepressant withdrawal are regularly mistaken to be other problems to the detriment of the patient.

New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.

After 15 years, the founder of SurvivingAntidepressants.org, Adele Framer, shares what she has learned about the science of withdrawing from psychiatric drugs.

New understandings of medication and withdrawal experiences warrant rethinking conceptualizations of health and “madness."

A new study looks at how online communities provide information and support for patients experiencing psychiatric drug withdrawal.

Study reveals most patients are dissatisfied with prescribers' support when discontinuing antidepressants.

A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.

A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.

Online communities are stepping in to help people facing withdrawal effects amass information and receive support for their withdrawal experiences.

Researchers interviewed doctors about the barriers that prevent them from being able to decrease excess medications.

A team in the Netherlands is currently investigating the effects of tapering off of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) during pregnancy....

Correcting unnecessary long-term antidepressant use is difficult and met with apprehension by providers and service-users.

When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.

A new study by Peter Groot and Jim van Os investigated whether tapering strips can help people stop using antidepressants.

Researchers from Germany, Greece and the U.S. reviewed the literature on relapse at 7 to 12 months following initiation of antipsychotic treatment. They conclude...

“Short and simple psychological programs can prevent people from relapsing when they stop their antidepressants.”